Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicara Therapeutics

12.42
-0.9300-6.97%
Post-market: 12.840.4200+3.38%16:22 EDT
Volume:746.12K
Turnover:9.60M
Market Cap:675.84M
PE:-0.69
High:14.04
Open:13.49
Low:12.01
Close:13.35
Loading ...

TD Cowen Initiates Coverage on Bicara Therapeutics with Buy Rating

MT Newswires Live
·
08 Oct 2024

Bicara Therapeutics Initiated at Buy by TD Cowen

Dow Jones
·
08 Oct 2024

Cantor Fitzgerald Initiates Coverage on Bicara Therapeutics With Overweight Rating

MT Newswires Live
·
08 Oct 2024

Bicara Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
08 Oct 2024

Bicara Therapeutics initiated with a Buy at Stifel

TIPRANKS
·
08 Oct 2024

Ficerafusp Alfa’s Market Potential and Novel Mechanism Spearhead Buy Rating for Bicara Therapeutics

TIPRANKS
·
08 Oct 2024

Bicara Therapeutics initiated with a Buy at TD Cowen

TIPRANKS
·
08 Oct 2024

Bicara Therapeutics: A Buy Rating on Promising Clinical Progress and Financial Fortitude

TIPRANKS
·
08 Oct 2024

Bicara Therapeutics initiated with an Overweight at Morgan StanleyMerus

TIPRANKS
·
08 Oct 2024

Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
28 Sep 2024

RA Capital Management's Strategic Acquisition of Bicara Therapeutics Shares

GuruFocus.com
·
24 Sep 2024

BRIEF-Ra Capital Management Lp Reports 12.8% Stake In Bicara Therapeutics As Of Sept 16 - SEC Filing

Reuters
·
24 Sep 2024

Ra Capital Management Lp Reports 12.8% Stake in Bicara Therapeutics as of Sept 16 - SEC Filing

THOMSON REUTERS
·
24 Sep 2024

FMR LLC Acquires New Stake in Bicara Therapeutics Inc

GuruFocus.com
·
19 Sep 2024

Bicara Therapeutics Closes $362 Million IPO

MT Newswires Live
·
17 Sep 2024

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
17 Sep 2024